Kallikrein-kinin in infection and cancer

Immunopharmacology

Volumn 43, Issue 2-3, 1999, Pages 115-128

  Maeda, Hiroshi ^a   Wu, Jun ^a   Okamoto, Tatsuya ^a   Maruo, Keishi ^a   Akaike, Takaaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

1 Protease inhibitor; HOE 140; Kinin cascade; Matrix metalloproteinases; Nitric oxide; Peroxynitrite; Vascular permeability

Indexed keywords

ARGININE; BRADYKININ; HIGH MOLECULAR WEIGHT KININOGEN; ICATIBANT; INDOMETACIN; KALLIKREIN; KALLIKREIN INHIBITOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; NITRIC OXIDE; PEROXYNITRITE; PROTEINASE; PROTEINASE INHIBITOR; SUPEROXIDE; TEMOCAPRIL;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CANCER; CONFERENCE PAPER; EDEMA; EXTRAVASATION; HUMAN; INFECTION; KALLIKREIN KININ SYSTEM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PAIN; PRIORITY JOURNAL; RAT; TUMOR GROWTH;

ALPHA 1-ANTITRYPSIN; ANIMALS; BACTERIAL INFECTIONS; CAPILLARY PERMEABILITY; COLLAGENASES; ENZYME PRECURSORS; HUMANS; KALLIKREIN-KININ SYSTEM; METALLOENDOPEPTIDASES; NEOPLASMS; NITRATES; NITRIC OXIDE;

EID: 0032755487     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00104-6     Document Type: Conference Paper

References (47)

1. 2 generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J. Clin. Invest. 85, 739-745.
2. Akaike, T., Yoshida, M., Miyamoto, Y., Sato, K., Kohno, M., Sasamoto, K., Miyazaki, K., Ueda, S., Maeda, H., 1993. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/ NO through a radical reaction. Biochemistry 32, 827-832.
3. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y.M., Dietzschold, B., Maeda, H., 1996. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. U.S.A. 93, 2448-2453.
4. Chan, D., Gera, L., Helfrich, B., Helm, K., Stewart, J., Whalley, E., Bunn, P., 1996. Novel bradykinin antagonist dimers for the treatment of human lung cancers. Immunopharmacology 33, 201-204.
5. Clearly, P.P., Prahbu, U., Dale, J.B., Wexler, D.E., Handley, J., 1992. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect. Immun. 60, 5219-5223.
6. Crow, J.P., Beckman, J.S., 1995. The role of peroxynitrite in nitric oxide-mediated toxicity. In: Kuprowski, H., Maeda, H. (Eds.), The Role of Nitric Oxide in Physiology and Pathophysiology. Springer-Verlag, Berlin, pp. 57-73.
7. Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., Maeda, H., 1996. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77, 1598-1604.
8. Doi, K., Akaike, T., Fujii, S., Tanaka, S., Ikebe, N., Beppu, T., Shibahara, S., Ogawa, M., Maeda, H., 1999. Induction of heme oxygenase-1 by nitric oxide and ischemia in experimental solid tumors and implications for tumor growth. Br. J. Cancer, in press.
9. Herwald, H., Collie, M., Müller-Esterl, W., Björck, L., 1996. Streptococcal cysteine proteinase release kinins. A novel virulence mechanism. J. Exp. Med. 184, 665-673.
10. Herwald, H., Mörgelin, M., Olsen, A., Rhen, M., Dahlbäck, B., Müller-Esterl, W., Björck, L., 1998. Activation of the contact-phase system or bacterial surfaces a clue to serious complications in infectious diseases. Nature Med. 4, 298-302.
11. Kamata, R., Yamamoto, T., Matsumoto, K., Maeda, H., 1985. A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs. Infect. Immun. 48, 747-753.
12. Kaminishi, H., Cho, T., Itoh, T., Iwata, A., Kawasaki, K., Hagihara, Y., Maeda, H., 1993. Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs. FEMS-Microbiol. Lett. 114, 109-114.
13. Katori, M., Majima, M., Odoi-Adome, R., Sunahara, N., Uchida, Y., 1989. Evidence for the involvement of a kallikrein-kinin system in the immediate hypotension produced by endotoxin. Br. J. Pharmacol. 98, 1381-1391.
14. Kennedy, A.R., 1998. Chemopreventive agents: protease inhibitors. Pharmacol. Ther. 78, 167-209.
15. MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., Chen, H., Mudgett, J.S., 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
16. Maeda, H., 1996. Role of microbial proteases in pathogenesis. Microbiol. Immun. 40, 685-699.
17. Maeda, H., Yamamoto, T., 1996. Pathogenic mechanisms induced by microbial proteases in microbial infection. Biol. Chem. Hoppe-Seyler 377, 217-226.
18. 3]bradykinin in ascitic fluid form a patient with gastric cancer. J. Biol. Chem. 263, 16051-16054.
19. Maeda, H., Noguchi, Y., Sato, K., Akaike, T., 1994. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res. 85, 331-334.
20. Maeda, H., Okamoto, T., Akaike, T., 1998. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol. Chem. 379, 193-200.
21. Maruo, K., Akaike, T., Inada, Y., Ohkubo, I., Ono, T., Maeda, H., 1993. Effect of microbial and mite proteases on low and high molecular weight kininogens. J. Biol. Chem. 268, 17711-17715.
22. Maruo, K., Akaike, T., Ono, T., Maeda, H., 1998. Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist. Infect. Immun. 66, 866-869.
23. Matheson, N.R., Wong, P.S., Schuyler, M., Travis, J., 1981. Interaction of human α-1-proteinase inhibitor with neutrophil myeloperoxidase. Biochemistry 20, 331-336.
24. Matsumoto, K., Yamamoto, T., Kamata, R., Maeda, H., 1984. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. J. Biochem. 96, 739-749.
25. Matsumura, Y., Kimura, M., Yamamoto, T., Maeda, H., 1988. Involvement of the kinin-generating cascade and enhanced vascular permeability in tumor tissue. Jpn. J. Cancer Res. 79, 1327-1334.
26. Matsumura, Y., Maruo, K., Kimura, M., Yamamoto, T., Konno, T., Maeda, H., 1991. Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn. J. Cancer Res. 82, 732-741.
27. Molla, A., Matsumura, Y., Yamamoto, T., Okamura, R., Maeda, H., 1987. Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin. Infect. Immun. 55, 2509-2517.
28. Molla, A., Yamamoto, T., Akaike, T., Miyoshi, S., Maeda, H., 1989. Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J. Biol. Chem. 264, 10589-10594.
29. 1-proteinase inhibitor by peroxynitrite. Chem. Res. Toxicol. 5, 425-431.
30. Naito, K., Kanbayashi, N., Nakajima, S., Murai, T., Arakawa, K., Nishimura, S., Okuyama, A., 1994. Inhibition of growth of human tumor cells in nude mice by a metalloprotease inhibitor. Int. J. Cancer 58, 730-735.
31. Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T., Maeda, H., 1989. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244, 974-976.
32. Okamoto, T., Akaike, T., Nagano, T., Miyajima, S., Suga, M., Ando, M., Ichimori, K., Maeda, H., 1997a. Activation of human neutrophil procollagenase by nitrogen dioxides and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342, 261-274.
33. Okamoto, T., Akaike, T., Suga, M., Tanase, S., Horie, H., Miyajima, S., Ando, M., Ichinose, Y., Maeda, H., 1997b. Activation of human matrix metalloproteinases by various bacterial proteinases. J. Biol. Chem. 272, 6059-6066.
34. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A., Sessa, W.C., 1997. Nitric oxide production contributes to the angiogenic properties of vascular endothelia growth factor in human endothelia cells. J. Clin. Invest. 100, 3131-3139.
35. Palmer, R.M., Ashton, D.S., Moncada, S., 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333, 664-666.
36. Ridger, V.C., Greenacre, S.A.B., Hands, R.L.C., Halliwell, B., Moore, P.K., Whiteman, M., Brain, S.D., 1997. Effect of peroxynitrite on plasma extravasation, microvascular blood flow and nociception in the rat. Br. J. Pharmacol. 122, 1083-1088.
37. Rubbo, H., Darley-Usmar, V., Freeman, B., 1996. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9, 809-820.
38. Sakata, Y., Akaike, T., Suga, M., Ijiri, S., Ando, M., Maeda, H., 1996a. Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol. Immunol. 40, 415-423.
39. Sakata, Y., Akaike, T., Khan, M.M.H., Ichinose, Y., Hirayama, H., Suga, M., Ando, M., Maeda, H., 1996b. Activation of bradykinin generating cascade by Vibrio cholerae protease. Immunopharmacology 33, 377-379.
40. Senger, D.R., Perauzzi, C.A., Feder, J., Dvorak, H.F., 1986. Highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46, 5629-5632.
41. Shimada, T., Kato, H., Maeda, H., Iwanaga, S., 1985. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: Analysis by fluorescence polarization. J. Biochem. 97, 1637-1644.
42. 1/2. Immunopharmacology 33, 369-373.
43. Umezawa, K., Akaike, T., Fujii, S., Suga, M., Setoguchi, K., Ozawa, A., Maeda, H., 1997. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect. Immun. 65, 2932-2940.
44. Wei, X.-Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.-P., Damo, X., Muller, W., Moncada, S., Liew, F.Y., 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
45. Wu, J., Akaike, T., Maeda, H., 1998a. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res. 58, 159-165.
46. Wu, J., Sawa, T., Akaike, T., Maeda, H., 1998b. Peroxynitrite and oxygen radical species: roles in EPR effect and the implication for solid tumor therapy. Symposium Abstract 3rd International Symposium on Polymer Therapeutics, London, p. 53.
47. Yoshida, M., Akaike, T., Wada, Y., Sato, K., Ikeda, K., Ueda, S., Maeda, H., 1994. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem. Biophys. Res. Commun. 202, 923-930.